|
[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.Diagnostic and treatment guidelines for liver failure (2012 version) [J].Chin J Hepatol, 2013, 21 (3) :177-183. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华肝脏病杂志, 2013, 21 (3) :177-183.
|
|
[2]NING Q.Prospect and progression on study associated with severe acute exacerbation of chronic hepatitis B[J].Chin J Hepatol, 2010, 18 (2) :81-84. (in Chinese) 宁琴.乙型肝炎重症化研究现状和发展趋势[J].中华肝脏病杂志, 2010, 18 (2) :81-84.
|
|
[3]NING Q, ZHU L, YAN WM.Prewarning of severe acute aggravation of chronic hepatitis B[J].Chin J Hepatol, 2010, 18 (11) :805-807. (in Chinese) 宁琴, 朱琳, 严伟明.乙型肝炎重症化的早期预警[J].中华肝脏病杂志, 2010, 18 (11) :805-807.
|
|
[4]YI RT, NIU YH, LIU HL, et al.Natural killer group 2a expressed on both peripheral CD3-CD56+NK cells and CD3+CD8+T cells plays a pivotal negative regulatory role in the progression of hepatitis B virus-related acute-on-chronic liver failure[J].J Interferon Cytokine Res, 2016, 36 (12) :689-697.
|
|
[5]YE YN, LIU J, GAO ZL, et al.Decreases in activated CD8+Tcells in patients with severe hepatitis B are related to outcomes[J].Dig Dis Sci, 2015, 60 (1) :136-145.
|
|
[6] LIU XY, SHI F, WANG HF, et al.Research of PD-1 expression in CD8+T cell of periphera I blood with HBV-associated acute-on chronic liver failure[J].Chin J Exp Clin Virol, 2010, 24 (2) :125-127. (in Chinese) 刘晓燕, 石峰, 王慧芬, 等.PD-1受体在HBV-ACLF患者外周血CD8+T细胞上的表达研究[J].中华实验和临床病毒学杂志, 2010, 24 (2) :125-127.
|
|
[7]WASMUTH HE, KUNZ D, YAGMUR E, et al.Patients with acute-on-chronic liver failure display‘sepsis-like’immuneparalysis[J].Hepatology, 2005, 42 (2) :195-201.
|
|
[8]SHI F, TIEN P, WANG FS, et al.Skewed ratios between CD3+Tcells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure[J].Biochem Biophys Res Commun, 2010, 402 (1) :30-36.
|
|
[9]AGGARWAL S, GHILARDI N, XIE MH, et al.Interleukin-23promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17[J].Bio Chem, 2003, 278 (3) :1910-1914.
|
|
[10]IWAKURA Y, ISHIGAME H.The IL-23/IL-17 axis in inflammation[J].Clin Invest, 2006, 116 (5) :1218-1222.
|
|
[11]ZHANG GL, XIE DY, GAO ZL, et al.Imbalance of interleukin-17-producing CD4+T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-onchronic liver failure[J].J Gastroenterol Hepatol, 2013, 28 (3) :513-521.
|
|
[12]LIANG XS, LI CZ, ZHOU Y, et al.Changes in circulating Foxp3+regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure[J].Gastroenterol, 2014, 20 (26) :8558-8571.
|
|
[13]SHEN C, YAN WZ, ZHAO CY, et al.Increased CD4+CD25+regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients[J].J Microbiol Immunol Infect, 2015, 48 (2) :137-146.
|
|
[14]EYERICH S, EYERICH K, PENNINO D, et al.Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling[J].Clin Invest, 2009, 119 (12) :3573-3585.
|
|
[15]MO RD, WANG P, LAI R, et al.Persistently elevated circulating Th22 reversely correlates with prognosis in HBV-related acute-on-chronic liver failure[J].J Gastroenterol Hepatol, 2017, 32 (3) :677-686.
|
|
[16]BERNSMEIER C, TRIANTAFYLLOU E, BRENIG R, et al.CD14+CD15-HLA-DR-myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure[J].Hepatology, 2017.[Epub ahead of print]
|
|
[17]YE H, WANG LY, WANG K.Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure[J].Gastroenterol, 2013, 19 (18) :2818-2825.
|
|
[18]LAI JL, LIU YM, ZHOU YP, et al.Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure[J].Exp Ther Med, 2017, 13 (6) :2867-2875.
|
|
[19]DU XX, SHI Y, YANG Q, et al.DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure[J].Liver Int, 2017.[Epub ahead of print]
|
|
[20]LUO GC, HUANG YL, ZHANG GY, et al.Research on the relationship between serum cytokine levels and prognosis in patients with HBV-related acute-on-chronic liver failure[J].Lab Med, 2014, 29 (1) :26-30. (in Chinese) 罗光成, 黄云丽, 张国元, 等.HBV相关慢加急性肝衰竭患者血清细胞因子水平与疾病预后的关系研究[J].检验医学, 2014, 29 (1) :26-30.
|
|
[21]LU J, HE JQ.Association of the changes in the levels of interleukin-6, interleukin-10, and tumor necrosis factor-αwith hepatic encephalopathy in patients with acute-on-chronic liver failure[J].Pract Clin Med, 2016, 17 (10) :16-18. (in Chinese) 炉军, 何金秋.慢加急性肝衰竭患者IL-6、IL-10、TNF-α水平变化与肝性脑病的关系[J].实用临床医学, 2016, 17 (10) :16-18.
|
|
[22]SUDO K, YAMADA Y, SAITO K, et al.TNF-αand IL-6 signals from the bone marrow derived cells are necessary for normal murine liver regeneration[J].Biochim Biophys Acta, 2008, 1782 (11) :671-679.
|
|
[23]TILG H, MOSCHEN AR, KANEIDER NC.Pathways of liver injuryin alcoholic liver disease[J].Hepatology, 2011, 55 (5) :1159-1161.
|
|
[24]ALAM A, CHUN SUEN K, MA D.Acute-on-chronic liver failure:recent update[J].J Biomed Res, 2017, 31 (3) :1-18.
|
|
[25]HUOVILA AP, TURNER AJ, PELTO-HUIKKO M, et al.Shedding light on ADAM metalloproteinases[J].Trends Biochem Sci, 2005, 30 (7) :413-422.
|
|
[26]VALAYDON Z, PELLEGRINI M, THOMPSON A, et al.The role of tumour necrosis factor in hepatitis B infection:Jekyll and Hyde[J].Clin Transl Immunology, 2016, 5 (12) :e115.
|
|
[27]WANG ZL, GAO S, WANG K, et al.Demethylation of tumor necrosis factor-αconverting enzyme predicts poor prognosis in acuteon-chronic hepatitis B liver failure[J].Clin Res Hepatol Gastroenterol, 2016, 40 (4) :457-464.
|
|
[28]YU XP, ZHENG YJ, DENG Y, et al.Serum interleukin (IL) -9and IL-10, but not T-helper 9 (Th9) cells, are associated with survival of patients with acute-on-chronic hepatitis B liver failure[J].Medicine, 2016, 95 (16) :e3405.
|
|
[29]ZOU ZS, LI BS, WANG FS, et al.Imbalanced intrahepatic cytokine expression of interferon-[gamma], tumor necrosis factor-[alpha], and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection[J].Clin Gastroenterol, 2009, 43 (2) :182-190.
|
|
[30]BERRY PA, ANTONIADES CG, HUSSAIN MJ, et al.Admission levels andearly changes in serum interleukin-10 are predictive of poor outcome in acute Iiver failure and decompensated cirrhosis[J].Liver Int, 2010, 30 (5) :733-740.
|
|
[31]MONNERET G, FINCK ME, VENET F, et al.The anti-inflammatory response dominates after septic shock:association of low monoeyte HLA-DR expression and high interleukin-10 concentration[J].Immunol Lett, 2004, 95 (2) :193-198.
|
|
[32]HU X, MA S, HOU JL, et al.Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease[J].J Viral Hepat, 2011, 18 (7) :458-467.
|
|
[33]BAO SX, ZHENG JM, LI N, et al.Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-onchronic liver failure and its correlation with the severity of liver damage[J].Clin Res Hepatol Gastroenterol, 2017, 41 (2) :147-155.
|
|
[34]MIWA Y, HARRISON PM, FARZANEH F, et al.Plasma levels and hepatic mRNA expression of transforming growth factor-beta1in patients with fulminant hepatic failure[J].Hepatol, 1997, 27 (5) :780-788.
|
|
[35]YOSHIMOTO N, TOGO S, KUBOTA T, et al.Role of transforming growth factor-beta1 (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats[J].Endotoxin Res, 2005, 11 (1) :33-39.
|
|
[36]YU XP, GUO RY, SU ZJ, et al.The transforming growth factorβ1/Interleukin-31 pathway is upregulated in patients with hepatitis B virus-related acute-on-chronic liver failure and is associated with disease severity and survival[J].Clin Vaccine Immunol, 2015, 22 (5) :484-492.
|
|
[37]GARG V, GARG H, KHAN A, et al.Granulocyte-colony stimulatingfactor mobilizes CD34 (+) cells and improves survival of patients with acute-on-chronic liver failure[J].Gastroenterology, 2012, 142 (3) :505-512.
|
|
[38]DUAN XZ, LIU FF, TONG JJ, et al.Granulocyte-colony stimulating factor therapy improves survival in patients withhepatitis B virus-associated acute-on-chronic liver failure[J].Gastroenterol, 2013, 19 (7) :1104-1110.
|
|
[39]KHANAM A, TREHANPATI N, GARG V, et al.Altered frequencies of dendritic cells and IFN gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on-chronic liver failure[J].Liver Int, 2014, 34 (4) :505-513.
|
|
[40]ANDERLINI P, PRZEPIORKA D, CHAMPLIN R, et al.Biologic andclinical effects of granulocyte colony-stimulating factor innormal individuals[J].Blood, 1996, 88 (8) :2819-2825.
|
|
[41]de HAAS M, KERST JM, van der SCHOOT CE, et al.Granulocytecolony-stimulating factor administration to healthy volunteers:analysis of the immediate activating effects on circulating neutrophils[J].Blood, 1994, 84 (11) :3885-3894.
|
|
[42]THOMAS JA, POPE C, WOJTACHA D, et al.Macrophage therapyfor murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function[J].Hepatology, 2011, 53 (6) :2003-2015.
|
|
[43]CHAVEZ-TAPIA NC, MENDIOLA-PASTRANA I, ORNELAS-ARROYO VJ, et al.Granulocyte-colony stimulating factor foracuteonchronicliver failure:systematic review andmeta-analysis[J].Ann Hepatol, 2015, 14 (5) :631-641.
|
DownLoad: